Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
F	O
Service:	O
MEDICINE	O
Allergies:	O
codeine	O
/	O
Sulfa	O
(Sulfonamide	O
Antibiotics)	O
Attending:	O
___.	O
Chief	O
Complaint:	O
Shortness	O
of	O
breath	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
Cardioversion	O
History	O
of	O
Present	O
Illness:	O
Ms.	O
___	O
is	O
an	O
___	O
y/o	O
lady	O
with	O
PMH	O
Afib	O
on	O
Rivaroxaban	O
s/p	O
recent	O
DCCV	O
(CHA2DS2-VASc	O
6),	O
NIDDM2,	O
HLD,	O
CKD,	O
depression,	O
presenting	O
with	O
worsening	O
dyspnea	O
on	O
exertion,	O
___	O
edema,	O
and	O
increased	O
abdominal	O
girth.	O
She	O
was	O
referred	O
for	O
direct	O
admission	O
from	O
her	O
cardiologist	O
Dr.	O
___	O
further	O
management	O
and	O
consideration	O
of	O
elective	O
LHC.	O
Pt	O
c/o	O
long	O
history	O
of	O
dyspnea	O
on	O
exertion,	O
worsening	O
over	O
a	O
few	O
weeks.	O
Afib	O
was	O
diagnosed	O
incidentally	O
during	O
a	O
hospitalization	O
a	O
few	O
years	O
ago	O
for	O
diabetes,	O
however	O
she	O
denies	O
having	O
been	O
on	O
any	O
rate	O
control	O
agent	O
or	O
anticoagulation	O
until	O
a	O
few	O
weeks	O
ago.	O
One	O
week	O
after	O
successful	O
cardioversion,	O
she	O
developed	O
shortness	O
of	O
breath	O
and	O
___	O
edema,	O
presented	O
to	O
PCP	O
___	O
___,	O
was	O
found	O
to	O
be	O
in	O
AF	O
again	O
with	O
rate	O
~100,	O
with	O
2+	O
___	O
edema	O
and	O
crackles.	O
She	O
was	O
reevaluated	O
___	O
with	O
respiratory	O
status	O
thought	O
to	O
be	O
slightly	O
worse,	O
prompting	O
request	O
for	O
admission.	O
At	O
office,	O
labs	O
notable	O
for	O
BUN	O
19,	O
creatinine	O
1.8,	O
sodium	O
133,	O
potassium	O
5.2,	O
glucose	O
219.	O
She	O
denies	O
dyspnea	O
at	O
rest,	O
previous	O
episodes	O
of	O
CHF,	O
chest	O
pain	O
at	O
rest/with	O
exertion,	O
orthopnea,	O
PND,	O
palpitations,	O
cough	O
or	O
recent	O
URI	O
symptoms,	O
weight	O
gain.	O
Reported	O
dry	O
weight	O
157	O
lbs.	O
ROS	O
positive	O
for	O
frequent	O
falls	B-Falls
at	O
home,	O
walks	B-Mobile_with_aid
with	O
a	O
cane.	B-Mobile_with_aid
A	O
few	O
weeks	O
ago,	O
her	O
"legs	O
gave	O
out"	O
and	O
she	O
fell	B-Falls
on	O
her	O
L	O
knee,	O
without	O
HS/LOC	O
or	O
cardiac	O
symptoms	O
related	O
to	O
the	O
fall.	B-Falls
Past	O
Medical	O
History:	O
PAST	O
MEDICAL	O
HISTORY:	O
=====================	O
1.	O
CARDIAC	O
RISK	O
FACTORS	O
-	O
Diabetes	O
mellitus	O
II	O
-	O
Hypertension	O
-	O
Hyperlipidemia	O
2.	O
CARDIAC	O
HISTORY	O
-	O
AF	O
diagnosed	O
___,	O
CHA2DS2-VASc	O
6,	O
on	O
rate	O
control	O
and	O
Rivaroxaban,	O
-	O
Electrical	O
cardioversion	O
for	O
afib	O
3.	O
OTHER	O
PAST	O
MEDICAL	O
HISTORY	O
-	O
Depression,	O
longstanding	O
after	O
son's	O
death	O
___	O
years	O
ago	O
-	O
hysterectomy	O
and	O
gallbladder	O
removal	O
Social	O
History:	O
___	O
Family	O
History:	O
Father	O
died	O
from	O
MI	O
in	O
his	O
___	O
Mother	O
died	O
when	O
pt	O
was	O
___	O
years	O
old,	O
had	O
gallbladder	O
removed	O
and	O
had	O
surgical	O
complications	O
3	O
sons:	O
2	O
deceased,	O
one	O
was	O
"on	O
drugs",	O
one	O
had	O
an	O
MI	O
in	O
his	O
___,	O
other	O
son	O
is	O
healthy	O
Physical	O
___:	O
ADMISSION	O
EXAM:	O
VITALS:	O
97.7	O
PO	O
115/80	O
88	O
18	O
95	O
RA	O
Wt:	O
157	O
lbs	O
(dry	O
wt	O
157	O
lbs)	O
GENERAL:	O
Well-developed,	O
well-nourished.	B-Malnutrition
NAD.	O
Mood,	O
affect	O
appropriate.	O
HEENT:	O
NCAT.	O
Sclera	O
anicteric.	O
Conjunctiva	O
pink,	O
no	O
pallor	O
or	O
cyanosis	O
of	O
the	O
oral	O
mucosa.	O
No	O
xanthelasma.	O
NECK:	O
Supple	O
with	O
JVP	O
approximately	O
mid-neck.	O
CARDIAC:	O
Regular	O
rate,	O
irregular	O
rhythm,	O
normal	O
S1,	O
S2.	O
No	O
murmurs/rubs/gallops.	O
No	O
thrills,	O
lifts.	O
LUNGS:	O
No	O
chest	O
wall	O
deformities,	O
scoliosis	O
or	O
kyphosis.	O
Resp	O
were	O
unlabored,	O
no	O
accessory	O
muscle	O
use.	O
Dry	O
crackles	O
___	O
way	O
up	O
R	O
lung,	O
___	O
way	O
up	O
L	O
lung,	O
no	O
wheezes	O
or	O
rhonchi.	O
ABDOMEN:	O
Soft,	O
NTND,	O
NABS,	O
no	O
guarding.	O
No	O
palpable	O
HSM.	O
Obese.	O
EXTREMITIES:	O
Moving	O
all	O
extremities	O
equally,	O
trace	O
___	O
edema	O
to	O
the	O
knees	O
b/l,	O
no	O
c/c.	O
SKIN:	O
No	O
significant	O
rashes,	O
L	O
chest	O
wall	O
1cm	O
deeply	O
erythematous	O
circular	O
papule.	O
R	O
knee	O
healing	O
abrasions.	O
PULSES:	O
Distal	O
pulses	O
palpable	O
and	O
symmetric	O
DISCHARGE	O
EXAM:	O
98.5	O
PO	O
BP99/63	O
L	O
Sitting	O
HR56	O
RR18	O
SaO2	O
94%RA	O
GENERAL:	O
elderly	O
woman	O
sitting	O
in	O
bedside	O
chair,	O
NAD,	O
A+Ox3	B-Delirium
HEENT:	O
normocephalic,	O
bruiseing	O
above	O
lip,	O
sclera	O
anicteric	O
LUNGS:	O
Mild	O
dry	O
crackles	O
bilaterally,	O
normal	O
WOB	O
at	O
rest	O
HEART:	O
RR,	O
irregular	O
rhythm,	O
no	O
murmurs,	O
rubs,	O
gallops	O
ABDOMEN:	O
soft,	O
nontender,	O
nondistended	O
EXTREMITIES:	O
trace	O
___	O
edema	O
bilaterally	O
in	O
ankles	O
SKIN:	O
no	O
rashes;	O
R	O
knee	O
has	O
healing	O
abrasions	O
from	O
previous	O
falls	O
PULSES:	O
distal	O
pulses	O
palpable	O
Pertinent	O
Results:	O
ADMISION	O
LABS	O
___	O
11:41PM	O
BLOOD	O
WBC-6.9	O
RBC-3.59*	O
Hgb-11.2	O
Hct-35.3	O
MCV-98	O
MCH-31.2	O
MCHC-31.7*	O
RDW-13.3	O
RDWSD-47.8*	O
Plt	O
___	O
___	O
11:41PM	O
BLOOD	O
___	O
PTT-35.8	O
___	O
___	O
11:41PM	O
BLOOD	O
Glucose-125*	O
UreaN-22*	O
Creat-1.7*	O
Na-139	O
K-5.6*	O
Cl-100	O
HCO3-27	O
AnGap-12	O
___	O
11:41PM	O
BLOOD	O
Albumin-4.0	O
Calcium-9.3	O
Phos-4.3	O
Mg-2.4	O
OTHER	O
___	O
11:41PM	O
BLOOD	O
ALT-21	O
AST-26	O
LD(LDH)-161	O
AlkPhos-40	O
TotBili-0.3	O
DISCHARGE	O
LABS	O
___	O
05:50AM	O
BLOOD	O
Calcium-9.7	O
Phos-4.2	O
Mg-2.1	O
___	O
05:50AM	O
BLOOD	O
Glucose-142*	O
UreaN-28*	O
Creat-1.5*	O
Na-142	O
K-4.8	O
Cl-102	O
HCO3-23	O
AnGap-17*	O
___	O
05:50AM	O
BLOOD	O
WBC-7.7	O
RBC-3.80*	O
Hgb-11.6	O
Hct-37.4	O
MCV-98	O
MCH-30.5	O
MCHC-31.0*	O
RDW-13.3	O
RDWSD-47.9*	O
Plt	O
___	O
IMAGING/REPORTS:	O
ECHO	O
___:	O
The	O
left	O
atrium	O
is	O
normal	O
in	O
size.	O
No	O
atrial	O
septal	O
defect	O
is	O
seen	O
by	O
2D	O
or	O
color	O
Doppler.	O
The	O
estimated	O
right	O
atrial	O
pressure	O
is	O
___	O
mmHg.	O
Left	O
ventricular	O
wall	O
thickness,	O
cavity	O
size,	O
and	O
global	O
systolic	O
function	O
are	O
normal	O
(LVEF=55%).	O
Due	O
to	O
suboptimal	O
technical	O
quality,	O
a	O
focal	O
wall	O
motion	O
abnormality	O
cannot	O
be	O
fully	O
excluded.	O
There	O
is	O
beat-to-beat	O
variability	O
of	O
the	O
left	O
ventricular	O
ejection	O
fraction	O
due	O
to	O
an	O
irregular	O
rhythm/premature	O
beats.	O
Right	O
ventricular	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
are	O
normal.	O
The	O
diameters	O
of	O
aorta	O
at	O
the	O
sinus,	O
ascending	O
and	O
arch	O
levels	O
are	O
normal.	O
The	O
aortic	O
valve	O
leaflets	O
(3)	O
appear	O
structurally	O
normal	O
with	O
good	O
leaflet	O
excursion	O
and	O
no	O
aortic	O
stenosis	O
or	O
aortic	O
regurgitation.	O
The	O
mitral	O
valve	O
leaflets	O
are	O
structurally	O
normal.	O
There	O
is	O
no	O
mitral	O
valve	O
prolapse.	O
Trivial	O
mitral	O
regurgitation	O
is	O
seen.	O
There	O
is	O
mild	O
pulmonary	O
artery	O
systolic	O
hypertension.	O
There	O
is	O
an	O
anterior	O
space	O
which	O
most	O
likely	O
represents	O
a	O
prominent	O
fat	O
pad.	O
IMPRESSION:	O
Normal	O
global	O
biventricular	O
systolic	O
function.	O
Mild	O
pulmonary	O
hypertension.	O
Atrial	O
rhythm	O
appears	O
to	O
be	O
atrial	O
tachycardia	O
or	O
atrial	O
flutter.	O
Prominent	O
anterior	O
fat	O
pad.	O
No	O
pericardial	O
effusion	O
seen.	O
T/C	O
SPINE	B-Vertebral_compression_fracture
XRAY	O
___:	O
C1-C6	O
visualized	O
on	O
the	O
lateral	O
projection.	O
Bones	O
appear	O
demineralized.	O
There	O
is	O
mild	O
anterolisthesis	O
of	O
C4	O
on	O
C5.	O
No	O
fracture	B-Vertebral_compression_fracture
seen.	O
No	O
prevertebral	O
soft	O
tissue	O
swelling.	O
Thoracic	O
spine:	B-Vertebral_compression_fracture
Bones	O
appear	O
diffusely	O
demineralized,	O
limiting	O
sensitivity	O
for	O
detecting	O
acute	O
fracture.	B-Vertebral_compression_fracture
No	O
definite	O
fracture	O
seen.	O
There	O
is	O
moderate	O
cardiomegaly	O
with	O
evidence	O
of	O
left	O
atrial	O
enlargement.	O
Calcification	O
in	O
the	O
aortic	O
arch	O
noted.	O
CT	B-Intracranial_haemorrhage
HEAD	B-Intracranial_haemorrhage
___:	O
No	O
acute	O
findings.	O
Probable	O
chronic	O
lacunar	O
infarct	O
in	O
left	O
thalamus.	O
Chronic	O
small	O
vessel	O
ischemic	O
changes.	O
Brain	B-Intracranial_haemorrhage
parenchymal	O
atrophy	O
CXR	O
___:	O
Enlarged	O
cardiac	O
silhouette.	O
No	O
evidence	O
of	O
pulmonary	O
edema.	O
Brief	O
Hospital	O
Course:	O
Ms.	O
___	O
is	O
a	O
___	O
year	O
old	O
woman	O
with	O
PMH	O
afib	O
on	O
rivaroxaban	O
s/p	O
DCCV	O
several	O
weeks	O
ago,	O
(CHA2DS2-VASc	O
6),	O
NIDDM2,	O
HLD,	O
CKD,	O
depression,	O
who	O
was	O
a	O
direct	O
admit	O
from	O
home	O
by	O
her	O
cardiologist	O
Dr.	O
___	O
management	O
of	O
?CHF	O
and	O
consideration	O
for	O
elective	O
L	O
heart	O
cath.	O
She	O
presented	O
with	O
worsening	O
dyspnea	O
on	O
exertion.	O
Stated	O
that	O
she	O
initially	O
felt	O
well	O
after	O
the	O
DCCV,	O
but	O
a	O
week	O
later	O
she	O
was	O
shopping	O
and	O
suddenly	O
had	O
SOB;	O
found	O
to	O
have	O
afib	O
again	O
at	O
her	O
PCP	O
(cardiologist)'s	O
office.	O
Her	O
SOB	O
is	O
not	O
consistent	O
with	O
CHF	O
picture,	O
more	O
likely	O
due	O
to	O
AF.	O
She	O
had	O
successful	O
cardioversion	O
on	O
___	O
to	O
sinus	O
rhythm.	O
#Progressive	O
Dyspnea	O
on	O
Exertion	O
Patient	O
states	O
she	O
has	O
had	O
worsening	O
SOB	O
with	O
exertion.	O
Previously	O
thought	O
to	O
be	O
CHF	O
exacerbation,	O
but	O
does	O
not	O
sound	O
like	O
typical	O
HF	O
picture	O
->	O
CXR	O
at	O
___	O
showed	O
no	O
pulmonary	O
edema	O
but	O
did	O
show	O
massive	O
cardiomegaly,	O
patient	O
is	O
at	O
her	O
reported	O
dry	O
weight	O
of	O
71.2kg,	O
patient	O
has	O
no	O
SOB	O
lying	O
down	O
but	O
gets	O
exertional	O
SOB.	O
BNP	O
4045,	O
stable	O
compared	O
to	O
result	O
at	O
PCP	O
___.	O
-most	O
likely	O
due	O
to	O
Afib	O
-home	O
flecainide	O
was	O
d/c'd	O
and	O
patient	O
switched	O
to	O
PO	O
amiodarone	O
200mg	O
BID	O
___	O
patient	O
will	O
need	O
f/u	O
TFTs,	O
LFTs,	O
PFTs	O
outpatient	O
-continued	O
on	O
rivaroxaban	O
for	O
afib,	O
15mg	O
-successful	O
cardioversion	O
on	O
___	O
#Recurrent	O
Atrial	O
fibrillation:	O
CHA2DS2-VASc	O
6,	O
rivaroxaban	O
for	O
anticoag.	O
-cardioverted	O
to	O
sinus	O
rhythm,	O
as	O
stated	O
above	O
___	O
on	O
CKD:	O
___	O
Crt	O
in	O
___	O
was	O
1.45,	O
is	O
now	O
1.5	O
#Falls:	O
Patient	O
reports	O
multiple	O
falls	B-Falls
at	O
home,	O
walks	B-Mobile_with_aid
with	B-Mobile_with_aid
cane	B-Mobile_with_aid
at	O
baseline.	O
*	O
patient	O
will	O
go	O
to	O
rehab	O
after	O
leaving	O
the	O
hospital	O
CHRONIC	O
ISSUES	O
==============	O
#T2DM:	O
Treated	O
with	O
ISS	O
in	O
hospital;	O
takes	O
glipizide	O
and	O
metformin	O
at	O
home	O
#Depression:	O
Continued	O
home	O
alprazolam,	O
paroxetine	O
-psyc	O
consulted;	O
and	O
felt	O
patient	O
at	O
low	O
risk	O
of	O
self-harm	O
#HLD:	O
Continued	O
home	O
pravastatin	O
TRANSITIONAL	O
ISSUES	O
Discharge	O
weight:	O
69.4	O
kg	O
Discharge	O
Cr:	O
1.5	O
Medication	O
changes:	O
Flecainide	O
and	O
metoprolol	O
were	O
discontinued;	O
Patient	O
was	O
continued	O
on	O
rivaroxaban	O
and	O
started	O
on	O
amiodarone	O
200mg	O
BID	O
on	O
___,	O
may	O
need	O
dose	O
adjustment.	O
-will	O
need	O
annual	O
PFTs,	O
TFTs,	O
and	O
LFTs	O
Medications	O
on	O
Admission:	O
The	O
Preadmission	O
Medication	O
list	O
is	O
accurate	O
and	O
complete.	O
1.	O
Pravastatin	O
20	O
mg	O
PO	O
QPM	O
2.	O
Furosemide	O
20	O
mg	O
PO	O
DAILY	O
3.	O
Flecainide	O
Acetate	O
50	O
mg	O
PO	O
Q12H	O
4.	O
Enalapril	O
Maleate	O
20	O
mg	O
PO	O
DAILY	O
5.	O
Metoprolol	O
Tartrate	O
50	O
mg	O
PO	O
TID	O
6.	O
MetFORMIN	O
(Glucophage)	O
250	O
mg	O
PO	O
BID	O
7.	O
GlipiZIDE	O
5	O
mg	O
PO	O
DAILY	O
8.	O
PARoxetine	O
20	O
mg	O
PO	O
DAILY	O
9.	O
ALPRAZolam	O
0.5	O
mg	O
PO	O
TID	O
10.	O
Cyanocobalamin	O
500	O
mcg	O
PO	O
DAILY	O
11.	O
Magnesium	O
Oxide	O
400	O
mg	O
PO	O
DAILY	O
constipation	B-Constipation
12.	O
Rivaroxaban	O
20	O
mg	O
PO	O
DAILY	O
Discharge	O
Medications:	O
1.	O
Amiodarone	O
200	O
mg	O
PO	O
BID	O
2.	O
Polyethylene	O
Glycol	O
17	O
g	O
PO	O
DAILY:PRN	O
CONSTIPATION	B-Constipation
3.	O
Senna	O
8.6	O
mg	O
PO	O
BID:PRN	O
CONSTIPATION	B-Constipation
4.	O
Rivaroxaban	O
15	O
mg	O
PO	O
DINNER	O
5.	O
ALPRAZolam	O
0.5	O
mg	O
PO	O
TID	O
6.	O
Cyanocobalamin	O
500	O
mcg	O
PO	O
DAILY	O
7.	O
Enalapril	O
Maleate	O
20	O
mg	O
PO	O
DAILY	O
8.	O
Furosemide	O
20	O
mg	O
PO	O
DAILY	O
9.	O
GlipiZIDE	O
5	O
mg	O
PO	O
DAILY	O
10.	O
Magnesium	O
Oxide	O
400	O
mg	O
PO	O
DAILY	O
constipation	B-Constipation
11.	O
MetFORMIN	O
(Glucophage)	O
250	O
mg	O
PO	O
BID	O
12.	O
PARoxetine	O
20	O
mg	O
PO	O
DAILY	O
13.	O
Pravastatin	O
20	O
mg	O
PO	O
QPM	O
Discharge	O
Disposition:	O
Extended	O
Care	O
Facility:	O
___	O
Discharge	O
Diagnosis:	O
Primary	O
diagnosis	O
Atrial	O
fibrillation	O
Secondary	O
diagnoses	O
DM2	O
HTN	O
HLD	O
Depression	O
Discharge	O
Condition:	O
Mental	O
Status:	O
Clear	B-Delirium
and	B-Delirium
coherent.	B-Delirium
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Ambulatory	B-Mobile_with_assistance
-	B-Mobile_with_assistance
requires	B-Mobile_with_assistance
assistance	B-Mobile_with_assistance
or	B-Mobile_with_assistance
aid	B-Mobile_with_aid
(walker	O
or	O
cane).	O
Discharge	O
Instructions:	O
Dear	O
Ms.	O
___,	O
You	O
presented	O
to	O
___	O
with	O
shortness	O
of	O
breath.	O
You	O
had	O
a	O
heart	O
condition	O
called	O
atrial	O
fibrillation,	O
which	O
was	O
causing	O
your	O
symptoms.	O
We	O
changed	O
your	O
heart	O
medicine	O
to	O
amiodarone	O
to	O
help	O
keep	O
your	O
heart	O
rhythm	O
normal.	O
You	O
also	O
received	O
a	O
cardioversion	O
and	O
your	O
heart	O
rate	O
and	O
rhythm	O
became	O
normal.	O
It	O
is	O
important	O
that	O
you	O
continue	O
taking	O
amiodarone	O
after	O
you	O
leave	O
the	O
hospital.	O
You	O
should	O
also	O
keep	O
take	O
your	O
rivaroxaban	O
this	O
well	O
reduce	O
your	O
chances	O
of	O
having	O
a	O
stroke.	O
Please	O
follow	O
up	O
with	O
your	O
cardiologist	O
Dr.	O
___	O
in	O
clinic.	O
Sincerely,	O
Your	O
___	O
care	O
team	O
Followup	O
Instructions:	O
___	O

